Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus MEDLINE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

IKKα-Mediated Noncanonical NF-κB Signaling Is Required To Support Murine Gammaherpesvirus 68 Latency In Vivo.

Title: IKKα-Mediated Noncanonical NF-κB Signaling Is Required To Support Murine Gammaherpesvirus 68 Latency In Vivo.
Authors: Cieniewicz B; Department of Microbiology and Immunology, Stony Brook Universitygrid.36425.36, Stony Brook, New York, USA.; Molecular and Cellular Biology Program, Stony Brook Universitygrid.36425.36, Stony Brook, New York, USA.; Kirillov V; Department of Microbiology and Immunology, Stony Brook Universitygrid.36425.36, Stony Brook, New York, USA.; Daher I; HIV and AIDS Malignancy Branch, National Cancer Institutegrid.48336.3a, Bethesda, Maryland, USA.; Li X; HIV and AIDS Malignancy Branch, National Cancer Institutegrid.48336.3a, Bethesda, Maryland, USA.; Oldenburg DG; Gundersen Medical Foundation, La Crosse, Wisconsin, USA.; Dong Q; Department of Microbiology and Immunology, Stony Brook Universitygrid.36425.36, Stony Brook, New York, USA.; Molecular and Cellular Biology Program, Stony Brook Universitygrid.36425.36, Stony Brook, New York, USA.; Bettke JA; Molecular and Cellular Biology Program, Stony Brook Universitygrid.36425.36, Stony Brook, New York, USA.; Marcu KB; Department of Biochemistry and Cell Biology, Stony Brook Universitygrid.36425.36, Stony Brook, New York, USA.; Department of Pathology, Stony Brook Universitygrid.36425.36, Stony Brook, New York, USA.; Krug LT; Department of Microbiology and Immunology, Stony Brook Universitygrid.36425.36, Stony Brook, New York, USA.; HIV and AIDS Malignancy Branch, National Cancer Institutegrid.48336.3a, Bethesda, Maryland, USA.
Source: Journal of virology [J Virol] 2022 May 25; Vol. 96 (10), pp. e0002722. Date of Electronic Publication: 2022 Apr 28.
Publication Type: Journal Article
Language: English
Journal Info: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE
Imprint Name(s): Publication: Washington Dc : American Society For Microbiology; Original Publication: Baltimore, American Society for Microbiology.
MeSH Terms: Herpesviridae Infections*/metabolism ; I-kappa B Kinase*/genetics ; I-kappa B Kinase*/metabolism ; NF-kappa B*/genetics ; NF-kappa B*/metabolism ; Rhadinovirus*/physiology ; Virus Latency*/genetics; Animals ; Mice ; Signal Transduction
Abstract: Noncanonical NF-κB signaling is activated in B cells via the tumor necrosis factor (TNF) receptor superfamily members CD40, lymphotoxin β receptor (LTβR), and B-cell-activating factor receptor (BAFF-R). The noncanonical pathway is required at multiple stages of B cell maturation and differentiation, including the germinal center reaction. However, the role of this pathway in gammaherpesvirus latency is not well understood. Murine gammaherpesvirus 68 (MHV68) is a genetically tractable system used to define pathogenic determinants. Mice lacking the BAFF-R exhibit defects in splenic follicle formation and are greatly reduced for MHV68 latency. We report a novel approach to disrupt noncanonical NF-κB signaling exclusively in cells infected with MHV68. We engineered a recombinant virus that expresses a dominant negative form of IκB kinase α (IKKα), named IKKα-SA, with S176A and S180A mutations that prevent phosphorylation by NF-κB-inducing kinase (NIK). We controlled for the transgene insertion by introducing two all-frame stop codons into the IKKα-SA gene. The IKKα-SA mutant but not the IKKα-SA.STOP control virus impaired LTβR-mediated activation of NF-κB p52 upon fibroblast infection. IKKα-SA expression did not impact replication in primary fibroblasts or in the lungs of mice following intranasal inoculation. However, the IKKα-SA mutant was severely defective in the colonization of the spleen and in the establishment of latency compared to the IKKα-SA.STOP control and wild-type (WT) MHV68 at 16 days postinfection (dpi). Reactivation was undetectable in splenocytes infected with the IKKα-SA mutant, but reactivation in peritoneal cells was not impacted by IKKα-SA. Taken together, the noncanonical NF-κB signaling pathway is essential for the establishment of latency in the secondary lymphoid organs of mice infected with the murine gammaherpesvirus pathogen MHV68. IMPORTANCE The latency programs of the human gammaherpesviruses Epstein-Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV) are associated with B cell lymphomas. It is critical to understand the signaling pathways that are used by gammaherpesviruses to establish and maintain latency in primary B cells. We used a novel approach to block noncanonical NF-κB signaling only in the infected cells of mice. We generated a recombinant virus that expresses a dominant negative mutant of IKKα that is nonresponsive to upstream activation. Latency was reduced in a route- and cell type-dependent manner in mice infected with this recombinant virus. These findings identify a significant role for the noncanonical NF-κB signaling pathway that might provide a novel target to prevent latent infection of B cells with oncogenic gammaherpesviruses.
References: Semin Immunol. 2006 Oct;18(5):290-6. (PMID: 16931038); Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3792-7. (PMID: 9520446); J Immunol. 2003 Jul 15;171(2):886-92. (PMID: 12847258); Immunol Rev. 2012 Mar;246(1):125-40. (PMID: 22435551); PLoS Pathog. 2011 Nov;7(11):e1002336. (PMID: 22110409); J Immunol. 2003 Jul 15;171(2):547-51. (PMID: 12847217); Cell Host Microbe. 2010 Jul 22;8(1):100-15. (PMID: 20638646); J Virol. 2014 Apr;88(8):3965-75. (PMID: 24501409); Front Oncol. 2020 May 14;10:600. (PMID: 32528868); J Virol. 2009 Mar;83(6):2563-74. (PMID: 19129458); J Virol. 2000 Aug;74(15):6964-74. (PMID: 10888635); Nat Genet. 1999 May;22(1):74-7. (PMID: 10319865); Br Med J. 1967 Apr 29;2(5547):290-1. (PMID: 6023123); Am J Pathol. 1987 Oct;129(1):86-91. (PMID: 2821817); Mol Cell Biol. 1994 Mar;14(3):1939-48. (PMID: 8114725); Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6359-64. (PMID: 17404218); Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):141-6. (PMID: 14691250); J Virol. 2007 Oct;81(19):10300-9. (PMID: 17634221); Immunity. 2002 Oct;17(4):525-35. (PMID: 12387745); Nat Cell Biol. 2010 Feb;12(2):193-9. (PMID: 20081837); Methods Mol Biol. 2010;634:421-30. (PMID: 20677001); J Virol. 2009 May;83(9):4435-46. (PMID: 19244329); J Biol Chem. 2007 Aug 24;282(34):24858-65. (PMID: 17597077); Blood. 1995 Aug 15;86(4):1276-80. (PMID: 7632932); EMBO J. 2009 May 6;28(9):1283-95. (PMID: 19322197); J Exp Med. 2000 Nov 20;192(10):1453-66. (PMID: 11085747); J Virol. 2000 Mar;74(6):2786-92. (PMID: 10684295); J Biol Chem. 2010 May 28;285(22):17148-55. (PMID: 20348096); Blood. 2000 Oct 1;96(7):2537-42. (PMID: 11001908); J Immunol. 2015 Feb 15;194(4):1819-31. (PMID: 25595793); Science. 2001 Aug 24;293(5534):1495-9. (PMID: 11520989); J Virol. 2012 Apr;86(8):4340-57. (PMID: 22318145); Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9399-404. (PMID: 15190178); Mol Immunol. 2008 Apr;45(7):1926-34. (PMID: 18068231); Virology. 2013 Jun 5;440(2):140-9. (PMID: 23541081); Annu Rev Virol. 2021 Sep 29;8(1):349-371. (PMID: 34586873); J Virol. 2007 Apr;81(8):3949-68. (PMID: 17287275); Am J Pathol. 2010 Aug;177(2):608-21. (PMID: 20566741); J Immunol. 1995 Aug 15;155(4):1685-93. (PMID: 7636227); J Immunol. 2010 Apr 15;184(8):4497-509. (PMID: 20231695); Cell Mol Biol Res. 1995;41(6):537-49. (PMID: 8777433); J Virol. 2018 Mar 14;92(7):. (PMID: 29343572); J Virol. 1999 Jun;73(6):4651-61. (PMID: 10233924); EMBO J. 2002 Oct 15;21(20):5375-85. (PMID: 12374738); N Engl J Med. 1995 May 4;332(18):1186-91. (PMID: 7700311); Mol Cell Biol. 2000 Feb;20(4):1170-8. (PMID: 10648602); PLoS Pathog. 2011 Nov;7(11):e1002346. (PMID: 22102809); Immunity. 2008 Mar;28(3):391-401. (PMID: 18313334); Blood. 2012 Jun 7;119(23):5467-77. (PMID: 22544702); J Virol. 2005 Mar;79(5):2891-9. (PMID: 15709008); Nat Immunol. 2008 Dec;9(12):1364-70. (PMID: 18997792); J Biol Chem. 2004 Jun 18;279(25):26243-50. (PMID: 15084608); J Virol. 2009 May;83(10):4732-48. (PMID: 19264770); Clin Infect Dis. 2010 Aug 1;51(3):350-8. (PMID: 20583924); Cell Host Microbe. 2014 Apr 9;15(4):457-70. (PMID: 24721574); Am J Pathol. 1992 Apr;140(4):769-74. (PMID: 1314023); Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1447-52. (PMID: 9037073); Nat Immunol. 2002 Oct;3(10):958-65. (PMID: 12352969); J Virol. 2003 Aug;77(15):8532-40. (PMID: 12857922); J Virol. 2008 May;82(9):4235-49. (PMID: 18305042); Nat Rev Immunol. 2018 May;18(5):309-324. (PMID: 29379212); Cell. 2007 Jan 26;128(2):369-81. (PMID: 17254973); Oncogene. 2005 Oct 20;24(46):6917-24. (PMID: 16007144); J Virol. 2012 Feb;86(4):1930-41. (PMID: 22130545); J Exp Med. 2001 Feb 19;193(4):417-26. (PMID: 11181694); Pathogens. 2017 Feb 16;6(1):. (PMID: 28212352); Cell Host Microbe. 2017 May 10;21(5):580-591.e7. (PMID: 28494239); Blood. 2006 Apr 15;107(8):3295-302. (PMID: 16380446); EMBO J. 1997 Oct 15;16(20):6131-40. (PMID: 9359753); Curr Top Microbiol Immunol. 2016;393:177-209. (PMID: 26275874); J Virol. 2010 Dec;84(24):13045-52. (PMID: 20926565); J Exp Med. 1997 Aug 29;186(5):731-7. (PMID: 9271588); J Immunol. 2016 Mar 15;196(6):2591-601. (PMID: 26851215); Front Microbiol. 2021 Mar 09;12:656979. (PMID: 33767688); Nat Rev Immunol. 2017 Sep;17(9):545-558. (PMID: 28580957); PLoS Pathog. 2007 Jan;3(1):e11. (PMID: 17257062); Science. 1994 Dec 16;266(5192):1865-9. (PMID: 7997879)
Grant Information: T32 AI007539 United States AI NIAID NIH HHS; T32AI007539 HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
Contributed Indexing: Keywords: IKKα; gammaherpesvirus; latency; lytic replication; noncanonical NF-κB signaling; viral pathogenesis; virus-host interactions
Substance Nomenclature: 0 (NF-kappa B); EC 2.7.11.10 (I-kappa B Kinase)
Entry Date(s): Date Created: 20220428 Date Completed: 20220527 Latest Revision: 20240923
Update Code: 20260130
PubMed Central ID: PMC9131860
DOI: 10.1128/jvi.00027-22
PMID: 35481781
Database: MEDLINE

Journal Article